ALYSSA GOPMAN: Open Payments
NPI 1669870325 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,433 in 64 payments from 16 companies in 2025. Trend: 2023 $2,587 · 2024 $2,321 · 2025 $2,433
Food & beverage: $2,234Education: $199
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $476 |
| Janssen Biotech, Inc. | 9 | $358 |
| LEO Pharma Inc. | 11 | $306 |
| Organon LLC | 3 | $226 |
| Amgen Inc. | 2 | $162 |
| ABBVIE INC. | 10 | $156 |
| PFIZER INC. | 2 | $149 |
| UCB, Inc. | 2 | $125 |
| Galderma Laboratories, L.P. | 3 | $98 |
| Arcutis Biotherapeutics, Inc. | 5 | $94 |
Products named: DUPIXENT, TREMFYA, VTAMA, OTEZLA, ADBRY, SKYRIZI, ANZUPGO, LITFULO.
Industry payments across NY — which companies pay providers there.
